.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Nimaaya Women’s Centre for Health is a leading name in Indian reproductive medicine, offering premier infertility treatment. Under the expert leadership of IVF specialist Dr. Pooja Nadkarni Singh, the centre has earned the trust of over 25,000 women. Additionally, the clinic offers comprehensive care ranging from initial consultation to maternity support. However, what truly distinguishes Nimaaya is its empathetic and deeply personalized care. Consequently, patients from across India and around the world trust this premier healthcare destination. Thus, the hospital has become a beacon of hope for couples navigating parenthood.
Infertility can arise due to multiple physiological factors. Therefore, a thorough clinical evaluation of both partners remains highly essential. At Nimaaya, doctors perform all diagnostic tests and maternity procedures under one roof. For instance, the facility offers specialized services like in vitro fertilization (IVF), fetal medicine, and andrology. Furthermore, they perform advanced laparoscopic surgeries to treat complex gynecological conditions. As a result, patients experience a seamless diagnostic and therapeutic journey.
Modern reproductive science relies heavily on precise embryological monitoring. Consequently, Nimaaya equips its advanced laboratories with state-of-the-art diagnostic systems. Specifically, they utilize artificial intelligence (AI) and time-lapse incubators to monitor embryo development continuously. Moreover, clinicians perform Preimplantation Genetic Testing (PGT) to screen for chromosomal abnormalities. Because of these advanced interventions, successful treatment outcomes have increased significantly. Additionally, Dr. Pooja Nadkarni Singh and her skilled embryologists, including Dr. Prabhakar Singh, maintain international standards of care. Ultimately, this integration of technology and empathy ensures the highest clinical success.
Q1: What advanced fertility technologies are available at Nimaaya?
Specifically, Nimaaya utilizes artificial intelligence (AI) enabled services and time-lapse incubators. Additionally, they offer Preimplantation Genetic Testing (PGT) to enhance treatment success rates.
Q2: Why is a dual-partner evaluation necessary for infertility treatment?
Infertility can arise from both male and female factor issues. Therefore, evaluating both partners ensures an accurate diagnosis and a highly targeted treatment plan.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Discover how Nimaaya Women’s Centre, led by Dr. Pooja Nadkarni Singh, provides world-class infertility treatment and comprehensive maternity care in India....
4 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
